Jean Claude Pairon

Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions

Nicolas Alcala, Lise Mangiante, Nolwenn Le Stang et al. · EBioMedicine · 2019 · 79 citations · Full text

Medicine, Oncology, Pathology +17

Occupations and industries in France at high risk for pleural mesothelioma: A population‐based case–control study (1998–2002)

Patrick Rolland, Céline Gramond, Aude Lacourt et al. · American Journal of Industrial Medicine · 2010 · 50 citations

Public Health, Oncology, Pathology +17

Lymphohistiocytoid Variant of Malignant Mesothelioma of the Pleura: A Series of 22 Cases

Françoise Galateau-Sallé, Richard Attanoos, A R Gibbs et al. · The American Journal of Surgical Pathology · 2007 · 47 citations

Veterinary Medicine, Oncology, Pathology +17

Plasma Cell Membrane Localization of c-MET Predicts Longer Survival in Patients with Malignant Mesothelioma: A Series of 157 Cases from the MESOPATH Group

Guénaëlle Levallet, Mélissa Vaisse-Lesteven, Nolwenn Le Stang et al. · Journal of Thoracic Oncology · 2012 · 45 citations

Medicine, Oncology, Pathology +7

Asbestos‐related pleural diseases: Dimensional criteria are not appropriate to differentiate diffuse pleural thickening from pleural plaques

J. Ameille, M. Matrat, Christophe Paris et al. · American Journal of Industrial Medicine · 2004 · 25 citations

Medicine, Radiology, Pulmonary Function Testing +12